Showing results (61-70 of 135) with videos related to
Sort By:
Pageof 14
Journal of Virology|January 1, 1977
Steroid induction of mouse mammary tumor virus: effect upon synthesis and degradation of viral RNAH A Young, T Y Shih, E M Scolnick, et al.Oncogene|October 20, 2000
Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-kappaB inhibitionQ Cheng, H H Lee, Y Li, et al.The Journal of Biological Chemistry|April 3, 2002
HTLV-1 Tax-associated hTid-1, a human DnaJ protein, is a repressor of Ikappa B kinase beta subunitHua Cheng, Carlo Cenciarelli, Mingyuan Tao, et al.Journal of the National Cancer Institute|August 1, 1981
Lymphoproliferative responses to mouse mammary tumor virus in lymphocyte subsets of breast cancer patientsD M Lopez, W P Parks, M A Silverman, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1971
Antibody to the RNA-dependent DNA polymerase of mammalian C-type RNA tumor virusesS A Aaronson, W P Parks, E M Scolnick, et al.Biochemistry|May 3, 1977
In vitro transcription of Moloney leukemia virus genes in infected cell nuclei and chromatin: elongation of chromatin associated ribonucleic acid by Escherichia coli ribonucleic acid polymeraseT Y Shih, H A Young, W P Parks, et al.The Journal of Infectious Diseases|April 1, 1987
Simultaneous infections with human T cell leukemia virus type I and the human immunodeficiency virusS B Kanner, E S Parks, G B Scott, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1972
Affinity chromatography of RNA-dependent DNA polymerase from RNA tumor viruses on a solid phase immunoadsorbentD M Livingston, E M Scolnick, W P Parks, et al.Journal of Virology|September 1, 1974
Immunological cross-reactions between two low-molecular-weight polypeptides from a murine type C virusW P Parks, E M Scolnick, M C Noon, et al.Allergy Proceedings : the Official Journal of Regional and State Allergy Societies|September 1, 1993
Systemic reactions to immunotherapyS M Matloff, I W Bailit, P Parks, et al.Pageof 14